Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclopofol dose-finding with low-dose sufentanil for painless gastroscopy in obese adults
ChiCTR2300074216Phase 4Not yet recruiting
- Sponsor
- Hangzhou Red Cross Hospital
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofol and sufentanil, sponsored by Hangzhou Red Cross Hospital. Primary endpoint: Loss of consciousness. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
ciprofolsufentanil
Beyond the preview
Go deeper on ChiCTR2300074216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074216.